FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289201412> ?p ?o ?g. }

• W4289201412 endingPage "3993" @default.
• W4289201412 startingPage "3981" @default.
• W4289201412 abstract "Hepatocellular carcinoma (HCC) is a common tumour often diagnosed with a multifocal presentation. Patients with multifocal HCC represent a heterogeneous group. Although Trans-Arterial ChemoEmbolization (TACE) is the most frequently employed treatment for these patients, previous data suggested that liver resection (LR) could be a safe and effective procedure.To compare LR and TACE in patients with multifocal HCC in terms of procedure-related morbidity and oncologic outcomes.All patients with multifocal HCC who underwent LR or TACE as the first procedure between May 2011 and March 2021 were enrolled. The decision to perform surgery or TACE was made after a multidisciplinary team evaluation. Only patients in Child-Pugh class A or B7 and stage B (according to the Barcelona Clinic Liver Cancer staging system, without severe portal hypertension, vascular invasion, or extrahepatic spread) were included in the final analysis. Propensity score matching was used to adjust the baseline differences between patients undergoing LR and the TACE group [number and diameter of lesions, presence of cirrhosis, alpha-fetoprotein (AFP) levels, and Model for End-Stage Liver Disease score]. The Kaplan-Meier method was used to estimate overall survival (OS) and disease-free survival (DFS). The outcomes of LR and TACE were compared using the log-rank test.After matching, 30 patients were eligible for the final analysis, 15 in each group. Morbidity rates were 42.9% and 40% for LR and TACE, respectively (P = 0.876). Median OS was not different in the LR and TACE groups (53 mo vs 18 mo, P = 0.312), while DFS was significantly longer with LR (19 mo vs 0 mo, P = 0.0001). Subgroup analysis showed that patients in the Italian Liver Cancer (ITA.LI.CA) B2 stage, with AFP levels lower than 400 ng/mL, less than 3 lesions, and lesions bigger than 41 mm, benefited more from LR in terms of DFS. Patients classified as ITA.LI.CA B3, with AFP levels higher than 400 ng/mL and with more than 3 lesions, appeared to receive more benefit from TACE in terms of OS.In a small cohort of patients with multifocal HCC, LR confers longer DFS compared with TACE, with similar OS and post-procedural morbidity." @default.
• W4289201412 created "2022-08-01" @default.
• W4289201412 creator A5003128381 @default.
• W4289201412 creator A5011905814 @default.
• W4289201412 creator A5014749257 @default.
• W4289201412 creator A5022764324 @default.
• W4289201412 creator A5033668654 @default.
• W4289201412 creator A5050786916 @default.
• W4289201412 creator A5069099319 @default.
• W4289201412 creator A5076657757 @default.
• W4289201412 creator A5080605194 @default.
• W4289201412 creator A5082342925 @default.
• W4289201412 creator A5084325745 @default.
• W4289201412 creator A5084871532 @default.
• W4289201412 date "2022-08-07" @default.
• W4289201412 modified "2023-10-14" @default.
• W4289201412 title "Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis" @default.
• W4289201412 cites W1971530401 @default.
• W4289201412 cites W1975154077 @default.
• W4289201412 cites W1979676741 @default.
• W4289201412 cites W1993975913 @default.
• W4289201412 cites W2039800254 @default.
• W4289201412 cites W2052552898 @default.
• W4289201412 cites W2081885723 @default.
• W4289201412 cites W2094873643 @default.
• W4289201412 cites W2118698732 @default.
• W4289201412 cites W2125763116 @default.
• W4289201412 cites W2143637070 @default.
• W4289201412 cites W2144173184 @default.
• W4289201412 cites W2147172608 @default.
• W4289201412 cites W2162497208 @default.
• W4289201412 cites W2277004004 @default.
• W4289201412 cites W2321984805 @default.
• W4289201412 cites W2343903007 @default.
• W4289201412 cites W2392107362 @default.
• W4289201412 cites W2465327389 @default.
• W4289201412 cites W2518446591 @default.
• W4289201412 cites W2546627132 @default.
• W4289201412 cites W2749321159 @default.
• W4289201412 cites W2762855963 @default.
• W4289201412 cites W286388250 @default.
• W4289201412 cites W2912034993 @default.
• W4289201412 cites W2914852118 @default.
• W4289201412 cites W2920826055 @default.
• W4289201412 cites W3025022288 @default.
• W4289201412 cites W3125788566 @default.
• W4289201412 cites W3157924430 @default.
• W4289201412 cites W3163483026 @default.
• W4289201412 cites W3213277274 @default.
• W4289201412 cites W4210774372 @default.
• W4289201412 doi "https://doi.org/10.3748/wjg.v28.i29.3981" @default.
• W4289201412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36157535" @default.
• W4289201412 hasPublicationYear "2022" @default.
• W4289201412 type Work @default.
• W4289201412 citedByCount "2" @default.
• W4289201412 countsByYear W42892014122023 @default.
• W4289201412 crossrefType "journal-article" @default.
• W4289201412 hasAuthorship W4289201412A5003128381 @default.
• W4289201412 hasAuthorship W4289201412A5011905814 @default.
• W4289201412 hasAuthorship W4289201412A5014749257 @default.
• W4289201412 hasAuthorship W4289201412A5022764324 @default.
• W4289201412 hasAuthorship W4289201412A5033668654 @default.
• W4289201412 hasAuthorship W4289201412A5050786916 @default.
• W4289201412 hasAuthorship W4289201412A5069099319 @default.
• W4289201412 hasAuthorship W4289201412A5076657757 @default.
• W4289201412 hasAuthorship W4289201412A5080605194 @default.
• W4289201412 hasAuthorship W4289201412A5082342925 @default.
• W4289201412 hasAuthorship W4289201412A5084325745 @default.
• W4289201412 hasAuthorship W4289201412A5084871532 @default.
• W4289201412 hasBestOaLocation W42892014121 @default.
• W4289201412 hasConcept C10515644 @default.
• W4289201412 hasConcept C126322002 @default.
• W4289201412 hasConcept C141071460 @default.
• W4289201412 hasConcept C146357865 @default.
• W4289201412 hasConcept C151730666 @default.
• W4289201412 hasConcept C17923572 @default.
• W4289201412 hasConcept C2776231280 @default.
• W4289201412 hasConcept C2777214474 @default.
• W4289201412 hasConcept C2777546739 @default.
• W4289201412 hasConcept C2778019345 @default.
• W4289201412 hasConcept C2778455285 @default.
• W4289201412 hasConcept C66339696 @default.
• W4289201412 hasConcept C71924100 @default.
• W4289201412 hasConcept C86803240 @default.
• W4289201412 hasConcept C90924648 @default.
• W4289201412 hasConceptScore W4289201412C10515644 @default.
• W4289201412 hasConceptScore W4289201412C126322002 @default.
• W4289201412 hasConceptScore W4289201412C141071460 @default.
• W4289201412 hasConceptScore W4289201412C146357865 @default.
• W4289201412 hasConceptScore W4289201412C151730666 @default.
• W4289201412 hasConceptScore W4289201412C17923572 @default.
• W4289201412 hasConceptScore W4289201412C2776231280 @default.
• W4289201412 hasConceptScore W4289201412C2777214474 @default.
• W4289201412 hasConceptScore W4289201412C2777546739 @default.
• W4289201412 hasConceptScore W4289201412C2778019345 @default.
• W4289201412 hasConceptScore W4289201412C2778455285 @default.
• W4289201412 hasConceptScore W4289201412C66339696 @default.
• W4289201412 hasConceptScore W4289201412C71924100 @default.

• next